dc.contributor.author | Henao-Restrepo, Ana Maria | |
dc.contributor.author | Camacho, Anton | |
dc.contributor.author | Longini, Ira M | |
dc.contributor.author | Watle, Sara Sofie Viksmoen | |
dc.contributor.author | Norheim, Gunnstein | |
dc.contributor.author | Røttingen, John-Arne | |
dc.contributor.author | Watson, Conall H. | |
dc.contributor.author | Edmunds, W John | |
dc.contributor.author | Matthias, Egger | |
dc.contributor.author | W Caroll, Miles | |
dc.contributor.author | Dean, Natalie E | |
dc.contributor.author | Ibrahima, Diatta | |
dc.contributor.author | Doumbia, Moussa | |
dc.contributor.author | Draguez, Bertrand | |
dc.contributor.author | Duraffour, Sophie | |
dc.contributor.author | Enwere, Godwin | |
dc.contributor.author | Grais, Rebecca | |
dc.contributor.author | Gunther, Stephan | |
dc.contributor.author | Gsell, Pierre-Stéphane | |
dc.contributor.author | Hossmann, Stefanie | |
dc.contributor.author | Konde, Mandy Kader | |
dc.contributor.author | Keita, Sakoba | |
dc.contributor.author | Kone, Souleymane | |
dc.contributor.author | Kuisma, Eeva | |
dc.contributor.author | Levine, Myron M. | |
dc.contributor.author | Mandal, Sema | |
dc.contributor.author | Mauget, Thomas | |
dc.contributor.author | Riveros, Ximena | |
dc.contributor.author | Soumah, Aboubacar | |
dc.contributor.author | Trelle, Sven | |
dc.contributor.author | Vicari, Andrea S. | |
dc.contributor.author | Kieny, Marie-Paule | |
dc.date.accessioned | 2017-11-02T15:47:34Z | |
dc.date.available | 2017-11-02T15:47:34Z | |
dc.date.created | 2017-03-02T08:57:24Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | The Lancet. 2016, 389 (10068), 505-518. | |
dc.identifier.issn | 0140-6736 | |
dc.identifier.uri | http://hdl.handle.net/11250/2463823 | |
dc.language.iso | eng | |
dc.relation.uri | http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)32621-6/abstract | |
dc.title | Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!) | |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.description.version | publishedVersion | |
dc.source.pagenumber | 505-518 | |
dc.source.volume | 389 | |
dc.source.journal | The Lancet | |
dc.source.issue | 10068 | |
dc.identifier.doi | 10.1016/S0140-6736(16)32621-6 | |
dc.identifier.cristin | 1455195 | |
cristin.unitcode | 7502,4,15,0 | |
cristin.unitcode | 7502,4,9,0 | |
cristin.unitcode | 7502,4,0,0 | |
cristin.unitname | Vaksineforebyggbare sykdommer | |
cristin.unitname | Molekylærbiologi | |
cristin.unitname | Smittevern, miljø og helse | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 2A | |